YORBA LINDA, Calif.,
April 9, 2019 /PRNewswire/ -- In
a recent episode of the Liveyon 'Pure-Cast,' John Kosolcharoen, founder and CEO of Liveyon,
and Dr. Alan Gaveck, Director of Education, examined the state of
the regenerative industry—breaking down some of the most pressing
problems plaquing the stem cell field and offering real
solutions.
The crucial question asked on Liveyon's 'Pure-Cast,' a video
podcast focusing on uncovering the truth about the emerging field
of regenerative medicine, was "Is there a stem cell bubble?"
Comparing the industry to the housing market, Kosolcharoen
agreed a bubble does exist due to emerging companies in search of a
profit at the cost of cutting regulatory corners.
"I think there is a stem cell bubble," Kosolcharoen said on the
show. "You know when you see companies popping up all over the
place, when you see a stem cell clinic on every corner, when you
see advertisers in papers and people just in it for the money. It's
kind of been this smash and grab with the labs out there that we
found that have been, just not doing things correctly and cutting
corners."
Kosolcharoen brought light to companies conducting fraudulent
testing and doctoring numbers to enhance their brand while
promoting a faulty product—and called for manufactures to take more
responsibility.
"We see fraudulent testing, where companies had a test done and
then we found fraudulent documentation and tweaking of some of the
numbers to make themselves look better," Kosolcharoen said. "I
think all of those things will catch up to the industry and the FDA
is going to have to come in and put some type of heavy regulation
it."
But Kosolcharoen offered a silver lining, saying further FDA
regulation will clean up the industry and drive out fraudulent
companies. In fact, the FDA has said it will further investigate
and enforce regulations of stem cell companies in November 2020.
While these fraudulent companies ravage the regenerative
industry, Liveyon continues to provide an innovative take on
product research, development, manufacturing and distribution,
while prioritizing a commitment to safety and transparency. Founded
in 2016, Liveyon and Liveyon Labs Inc. are committed to achieving
unparalleled stem cell potency through high live nucleated cell
counts, while following validation protocols that produce an
extremely consistent product for the most efficacious outcomes. The
company's dynamic ability to adapt to changing market trends and
execute on opportunities has fortified its exponential growth and
the company is poised to continue making a huge impact in the
industry 2019.
Liveyon recently launched 'Liveyon Pure Cast,' to bring to light
the truth about this emerging field and connecting doctors,
researchers, patients, and the general public directly with
well-respected industry leaders. The podcast provides a
complimentary resource for clients of the company's new product
line.
The exclusive video series streams live every Monday, Wednesday
and Friday morning and features John Kosolcharoen, founder and
chief executive officer of Liveyon and Dr. Alan Gaveck, director of
education, Liveyon. Dr. Gaveck brings 13 years of experience in
both clinical and surgical medical treatments and the two hosts'
intellectual chemistry enhances the show's format, as they tackle
groundbreaking topics and introduce experts in the field of
regenerative medicine, including leading researchers and
physicians.
To stay up-to-date on the regenerative medicine industry and
receive notices of free upcoming live streaming video events,
please subscribe to 'Liveyon Pure-Cast.'
Media Contact:
James Buzzacco
212431@email4pr.com
844-548-3966
View original content to download
multimedia:http://www.prnewswire.com/news-releases/is-there-a-stem-cell-bubble-liveyon-ceo-education-director-discuss-the-state-of-the-regenerative-industry-300827740.html
SOURCE Liveyon Labs